Management of Diabetes Insipidus

Diagnostic Tests

• The American College of Radiology recommends an MRI of the sella with high-resolution pituitary protocols as the preferred diagnostic test for central diabetes insipidus 1
• Plasma copeptin levels >21.4 pmol/l in adults are diagnostic for nephrogenic DI, potentially avoiding the need for challenge testing, as recommended by the Endocrine Society 2
• Genetic testing is strongly recommended, especially in congenital cases, using massively parallel sequencing-based multigene panels that include at least AQP2, AVPR2, and AVP genes, as recommended by the Endocrine Society 2
• The following table outlines the diagnostic criteria for central diabetes insipidus:

1, 2

• Water deprivation test with desmopressin challenge is the gold standard for diagnosis, but genetic testing may be preferred to avoid potentially harmful diagnostic procedures, as recommended by the American College of Physicians 2

Treatment and Management

• Desmopressin is effective for central diabetes insipidus, but ineffective and not indicated for nephrogenic diabetes insipidus, as warned by the Endocrine Society 2
• First-line combination therapy for nephrogenic diabetes insipidus includes a thiazide diuretic (hydrochlorothiazide 25 mg once or twice daily) and amiloride if hypokalaemia develops, and considers prostaglandin synthesis inhibitors (NSAIDs), as recommended by the American Academy of Nephrology 2
• Management of combined DI must address both conditions, with a pharmacological approach including thiazide diuretics for the nephrogenic component and desmopressin for the central component, as recommended by the American Academy of Nephrology 2
• Fluid management should be carefully monitored to prevent worsening of hyponatremia, with recommended fluid rates as follows:

2

• Ensure unrestricted access to water to prevent dehydration in patients with diabetes insipidus, and consider dietary modifications such as a low-salt diet (<6 g/day or 2.4 g sodium) and a low-protein diet (<1 g/kg/day), as suggested by the Academy of Nutrition and Dietetics 2

Monitoring and Follow-up

• Regular laboratory monitoring is necessary for patients with diabetes insipidus, including electrolytes (Na, K, Cl, HCO₃), renal function (creatinine, eGFR), uric acid levels, and urine osmolality, as recommended by a medical guideline society 2
• Imaging studies, such as ultrasound of the urinary tract every 2-3 years, are recommended to detect hydronephrosis, bladder wall hypertrophy, and post-micturition residue in patients with nephrogenic diabetes insipidus, as suggested by a medical guideline society 2
• Monitor for complications such as hypernatremic dehydration (emergency in nephrogenic diabetes insipidus), urological complications (reported in 46% of nephrogenic diabetes insipidus patients), and hydronephrosis and bladder dysfunction in patients with diabetes insipidus, as recommended by a medical guideline society 2
• Scheduling follow-up appointments before discharge is recommended, as stated by the American Diabetes Association, to ensure continuous care 3

Special Considerations

• Genetic counseling is recommended for familial forms of DI, as suggested by the National Kidney Foundation 2
• Genetic counseling is essential for affected individuals and carriers, and discussion of inheritance patterns and family planning is crucial, as recommended by a medical guideline society 2
• Administration of hypotonic fluids, such as dextrose 5%, should be avoided in patients with central DI to prevent rapid development of hyponatremia, as recommended by the European Society of Endocrinology and the American Society of Nephrology 4
• Isosthenuria due to impaired salt reabsorption in thick ascending limb is characteristic of Bartter syndrome, with reduced or absent medullary concentration gradient 5
• Urine osmolality testing is recommended during follow-up to assess for secondary nephrogenic diabetes insipidus in Bartter syndrome 5
• Treatment of Bartter syndrome includes sodium chloride, potassium chloride, and fluid supplementation adjusted individually 5